Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3,994 CHF | +0.36% | +2.86% | +14.49% |
Apr. 18 | UBS Raises Givaudan to Neutral from Sell, Raises PT | MT |
Apr. 18 | GIVAUDAN : UBS raises its recommendation | CF |
Sales 2024 * | 7.19B 7.87B | Sales 2025 * | 7.54B 8.25B | Capitalization | 36.72B 40.17B |
---|---|---|---|---|---|
Net income 2024 * | 978M 1.07B | Net income 2025 * | 1.08B 1.19B | EV / Sales 2024 * | 5.66 x |
Net Debt 2024 * | 3.97B 4.34B | Net Debt 2025 * | 3.76B 4.12B | EV / Sales 2025 * | 5.37 x |
P/E ratio 2024 * |
37.5
x | P/E ratio 2025 * |
33.7
x | Employees | 16,260 |
Yield 2024 * |
1.79% | Yield 2025 * |
1.86% | Free-Float | 80.92% |
Latest transcript on Givaudan SA
1 day | +0.34% | ||
1 week | +2.86% | ||
Current month | -0.67% | ||
1 month | -1.89% | ||
3 months | +20.26% | ||
6 months | +41.25% | ||
Current year | +14.49% |
Managers | Title | Age | Since |
---|---|---|---|
Gilles Andrier
CEO | Chief Executive Officer | 63 | 01-09-30 |
Thomas Hallam
DFI | Director of Finance/CFO | 58 | 07-12-31 |
Investor Relations Contact | 45 | 23-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Olivier Filliol
BRD | Director/Board Member | 57 | 20-03-24 |
Tom Knutzen
BRD | Director/Board Member | 62 | - |
Calvin Grieder
CHM | Chairman | 68 | 13-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.39% | 121 M€ | -.--% | - | |
1.38% | 18 M€ | +4.24% | - | |
1.10% | 267 M€ | +6.75% | ||
1.02% | 49 M€ | +5.37% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 3,987 | +0.20% | 2 083 |
24-04-23 | 3,979 | +0.86% | 16,282 |
24-04-22 | 3,945 | -0.15% | 14,704 |
24-04-19 | 3,951 | +1.26% | 23,256 |
24-04-18 | 3,902 | +0.62% | 14,250 |
Delayed Quote Swiss Exchange, April 24, 2024 at 03:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.49% | 40.32B | |
+10.74% | 62.8B | |
-6.25% | 45.4B | |
+20.63% | 25.83B | |
+4.41% | 18.21B | |
+0.46% | 17.41B | |
+4.02% | 15.64B | |
-23.40% | 15.51B | |
-20.96% | 13.42B | |
+34.50% | 12.66B |
- Stock Market
- Equities
- GIVN Stock